Data as of 3:58pm ET
| -0.18 / -4.76%|
The 2 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +31.94% increase from the last price of 3.60.
The current consensus among 4 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.